BCM
PBYI icon

Bridgeway Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bridgeway Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Buy
775,341
+1,856
+0.2% +$12K 0.1% 274
2025
Q4 		$4.6M Buy
773,485
+339,924
+78% +$1.81M 0.1% 272
2025
Q3 		$2.3M Buy
433,561
+230,771
+114% +$979K 0.05% 507
2025
Q2 		$696K Buy
202,790
+121,690
+150% +$388K 0.02% 715
2025
Q1 		$240K Sell
81,100
-24,100
-23% -$75.4K 0.01% 882
2024
Q4 		$321K Buy
105,200
+800
+0.8% +$2.33K 0.01% 908
2024
Q3 		$266K Sell
104,400
-35,000
-25% -$106K 0.01% 1003
2024
Q2 		$454K Hold
139,400
– – 0.01% 881
2024
Q1 		$739K Buy
139,400
+15,000
+12% +$80.8K 0.02% 826
2023
Q4 		$539K Sell
124,400
-24,000
-16% -$79.5K 0.01% 923
2023
Q3 		$390K Hold
148,400
– – 0.01% 949
2023
Q2 		$524K Hold
148,400
– – 0.01% 882
2023
Q1 		$459K Buy
148,400
+28,300
+24% +$107K 0.01% 910
2022
Q4 		$508K Sell
120,100
-6,000
-5% -$20.7K 0.01% 877
2022
Q3 		$299K Hold
126,100
– – 0.01% 1040
2022
Q2 		$359K Sell
126,100
-50,000
-28% -$124K 0.01% 954
2022
Q1 		$507K Sell
176,100
-64,613
-27% -$167K 0.01% 929
2021
Q4 		$732K Buy
+240,713
New +$1.04M 0.01% 870

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bridgeway Capital Management's PBYI Position: Q1 2026 in Review

Bridgeway Capital Management increased its Puma Biotechnology (PBYI) stake by 0.24% in Q1 2026, buying an estimated $12K and bringing the position to 775,341 shares worth $4.95M. The position accounts for 0.1% of the portfolio, ranked #274.

Bridgeway Capital Management first reported a position in PBYI in Q4 2021 and has held it in 18 quarters since. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Bridgeway Capital Management held 775,341 shares of Puma Biotechnology worth $4.95M as of Q1 2026.
  • Bridgeway Capital Management bought 1,856 Puma Biotechnology shares in Q1 2026, an estimated $12K.
  • Puma Biotechnology made up 0.1% of Bridgeway Capital Management's portfolio in Q1 2026, its #274 holding.
  • Bridgeway Capital Management first reported a position in Puma Biotechnology in Q4 2021 and has held it in 18 quarters since.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.